Log in to save to my catalogue

Covid-19 Vaccine Protection among Children and Adolescents in Qatar

Covid-19 Vaccine Protection among Children and Adolescents in Qatar

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2731720118

Covid-19 Vaccine Protection among Children and Adolescents in Qatar

Publication information

Publisher

Boston: Massachusetts Medical Society

More information

Scope and Contents

Contents

The 10-μg dose of BNT162b2 led to modest, rapidly waning protection against Covid-19 in children 5 to 11 years old. The 30-μg dose in adolescents gave greater, more durable protection, more so in 12-to-14-year-olds than in 15-to-17-year-olds.

Alternative Titles

Full title

Covid-19 Vaccine Protection among Children and Adolescents in Qatar

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2731720118

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2731720118

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2210058

How to access this item